Non-small-cell lung carcinomas (NSCLCs) are resistant to the induction of apoptosis by conventional anticancer treatment. However, NSCLC cell lines are sensitive to the action of the broad protein kinase inhibitor, staurosporine (STS). In the NSCLC cell line U1810, STS induced the mitochondrial release of apoptosis-inducing factor (AIF) and cytochrome c (Cyt c) followed by activation of caspases, nuclear condensation, DNA fragmentation and finally cell death. Although preincubation of U1810 cells with the broad-spectrum caspase inhibitor z-VAD.fmk delayed the occurrence of nuclear apoptosis induced by STS, it did not impede mitochondrial alterations (such as the release of Cyt c and AIF) and cell death to occur. Moreover, the microinjection of neither Cyt c nor recombinant active caspase-3 into the cytoplasm promoted nuclear apoptosis-related changes in U1810 cells. Evaluation of the role of the caspase-independent factor AIF in STS-mediated death revealed that, upon immunodepletion of AIF, cytosols from STS-treated U1810 lost their capacity to induce nuclear condensation when incubated with isolated nuclei. In addition, microinjection of an anti-AIF antibody prevented AIF from translocating to the nuclei of STS-treated U1810 cells and reduced STSinduced cell death. Finally, although the transfectionenforced overexpression of AIF was not sufficient to induce cell death, it did enhance STS-mediated cell killing. Altogether, these results indicate that activation of caspases is not sufficient to kill U1810 cells and rather suggests an important role for the AIF-mediated mitochondrial-mediated death pathway.
Introduction
Apoptosis plays a central role in the regulation of normal tissue homeostasis and participates in the elimination of potentially dangerous cells including the precursors of tumor cells. Most currently used antitumor agents, including chemotherapeutic drugs and girradiation, kill cancer cells by stimulating the apoptotic machinery, and therapy resistance can be attributed, at least in part, to a disabled apoptotic program.
Majority of proapoptotic stimuli, including anticancer drugs, require a mitochondrion-dependent step that involves permeabilization of the outer mitochondrial membrane and the release of mitochondrial proteins normally located in the intermembrane space. Several among these proteins are potentially apoptogenic. Thus, cytochrome c (Cyt c) is released into the cytosol where it triggers the activation of a cascade of caspases resulting in the final activation of caspasedependent DNase (CAD), the DNase responsible for the oligonucleosomal DNA degradation. In contrast, apoptosis-inducing factor (AIF), the first caspase-independent cell death effector to be identified (Susin et al., 1999) , translocates from mitochondria via the cytosol to the nucleus , where it interacts with DNA and the latent DNase cyclophilin A (Cande et al., 2004) and causes nuclear condensation and formation of 50 kbp DNA fragments (Ye et al., 2002) . AIF has been reported to play a major role in relevant experimental models of cell death induction like DNA damagemediated p53 activation (Cregan et al., 2002) or poly(ADP-ribose) polymerase (PARP)-mediated neuronal cell death following NMDA receptor stimulation .
Non-small-cell lung carcinomas (NSCLCs) exhibit an intrinsic resistance to chemo-and radiotherapy and NSCLC cell lines can be used to study the mechanisms of apoptosis resistance. We previously demonstrated that NSCLC cell lines, in contrast to small cell lung carcinoma (SCLC) cells, were crossresistant to apoptosis induced by DNA-damaging agents such as etoposide or g-radiation (Joseph et al., 2001) . We also found that the deficiency in the apoptotic pathway triggered by DNAdamaging agents occurred downstream from (or at the level of) mitochondrial changes and caspase activation, and upstream from nuclear apoptotic changes. Moreover, a defective caspase-3 relocalization from the cytosol into the nucleus was observed upon treatment of NSCLC cells. However, we found that, despite these deficiencies, the NSCLC cell lines were killed by the protein kinase inhibitor staurosporine (STS). STS induced both caspase activation and mitochondrial dysfunction associated with AIF release in NSCLC cells. Our results suggested that mitochondrial dysfunction was an important step in killing NSCLC resistant to conventional treatment.
To further explore the mechanisms of aberrant apoptosis regulation in NSCLC, we evaluated the contribution of the two mitochondrial cell death pathways, namely the Cyt c/caspase-dependent and the AIFdependent pathways, to STS-mediated NSCLC killing. Better understanding of mitochondrial cell death pathways may provide insights into sensitivity or resistance of tumor cells. Moreover, this knowledge could be further exploited to restore efficient apoptotic pathways in order to increase sensitivity of NSCLC to therapy. Here, we provide evidence that AIF plays a major role in the death of NSCLC, while the Cyt c/caspasedependent arm of the lethal signal transduction appears to be heavily compromised.
Results

Kinetics of apoptosis-associated changes in STS-treated U1810 cells
We previously reported that the induction of nuclear apoptosis by STS in U1810 cells is accompanied by mitochondrial dysfunction, release of proapoptotic proteins and activation of both caspase-dependent and -independent pathways . A kinetic analysis of the appearance of the main signs of apoptosis in STS-treated cells revealed a rapid (within 2 h) release of the mitochondrial proteins AIF and Cyt c into the cytosol of U1810 cells (Figure 1a ). Subcellular distribution of AIF was monitored by immunofluorescence confocal laser microscopy ( Figure 1b) . The mitochondrion-nuclear translocation of AIF was observed as early as 8 h after STS treatment, at the same time when PI-detectable chromatin condensation became apparent (Figure 1b) . The release of mitochondrial proteins was followed by the processing of caspase-3 and the cleavage of the nuclear protein PARP detected by Western blot 8 and 12 h after STS treatment, respectively (Figure 1c and d). Thus, in STS-induced apoptosis, the release of the mitochondrial proteins AIF and Cyt c precedes the downstream events of the apoptotic cascade including caspase-3 activation and nuclear condensation.
Effect of caspase inhibition on STS-induced nuclear events and cell death
The broad-spectrum caspase inhibitor z-VAD.fmk inhibited PARP cleavage in U1810 cells (Figure 1d ) at a concentration that completely inhibited activity of caspase-3-like proteases (data not shown). Earlier, we found that z-VAD.fmk was able to inhibit caspase activation and cell death in different cell lines (Jurkat, U1285 and H82) . To further examine the implication of caspases in our model, z-VAD.fmk pretreated U1810 cells were exposed to STS and analysed for apoptosis-associated nuclear and plasma membrane changes (Figure 2 ). z-VAD.fmk significantly suppressed the 'ladder type' DNA fragmentation observed at 18 h after incubation with STS ( Figure 2a) . However, z-VAD.fmk did not affect the release of mitochondrial proteins (Figure 2c) , confirming that the STS-triggered release of AIF and Cyt c occurs in a caspase-independent fashion. U1810 cells also developed large-scale DNA fragmentation to B50 kbp occurring within 4 h after STS exposure (Figure 2b ) far before activation of caspase-3-like enzymes. The STSinduced large-scale DNA fragmentation was not influenced by preincubation with z-VAD.fmk (Figure 2b ), in accord with previously published reports demonstrating that this type of DNA degradation is indeed caspaseindependent . Next, we tested the effect of z-VAD.fmk on the STS-triggered manifestation of apoptosis at the level of the plasma membrane, that is the exposure of PS residues to the cell surface and the subsequent loss of plasma membrane permeability. z-VAD.fmk failed to prevent these changes ( Figure 2d ). Next, we assessed the clonogenic U1810 cell survival (rather than cell death) upon treatment with STS and/or z-VAD.fmk ( Figure 2e ). As expected, STS treatment for 24 h caused a major reduction of cell survival, and this reduction was not affected by z-VAD.fmk, used at doses as high as 50 mM (Figure 2e ) or higher (data not shown).
Altogether, these results demonstrate that cell death induced by STS in U1810 occurs in a largely caspaseindependent fashion, despite the fact that caspases promoted some important phenomenological features of apoptosis in these cells.
Caspase-dependent mitochondrial pathway is unable to promote apoptosis-related nuclear changes in U1810 cells
We previously demonstrated that U1810 cells were resistant to etoposide-and g-radiation-induced apoptosis even though mitochondrial release of Cyt c and activation of caspase-3 were detectable (Joseph et al., 2001 ). To further document the level of the blockage of the caspase-dependent mitochondrial pathway of apoptosis in this model, we injected Cyt c (Figure 3 ) or recombinant active caspase-3 (Figure 4 ) into U1810 cells and quantitatively evaluated apoptosis-related nuclear changes. In contrast to the 3T3 cells used as controls, U1810 cells were completely resistant to death induced by Cyt c microinjection (Figure 3a) . Indeed, Cyt cmicroinjected U1810 cells were morphologically normal without any nuclear abnormalities (Figure 3b) . Moreover, no AIF release was observed (Figure 3b ). These negative results, however, did not exclude the possibility that, in U1810 cells, microinjected Cyt c could have been unable to promote caspase activation. Therefore, microinjection experiments were also performed with recom-binant active caspase-3 (Figure 4 ). While 75% of caspase-3-microinjected 3T3 cells were dead after 8 h, only 21% of microinjected U1810 cells presented nuclear changes (Figure 4a ). This difference in the caspase-3-induced mortality persisted for up to 24 h (data not shown). Again, no AIF release was observed in U1810 cells after active caspase-3 microinjection (Figure 4b ). Altogether, these results underscore the notion that the caspase-dependent mitochondrial pathway of apoptosis is deficient in U1810 cells downstream of caspase-3.
Protection against STS cytotoxicity by microinjection of AIF neutralizing antibodies
AIF is the prototypic mitochondrial caspase-independent factor in mammals . We therefore evaluated the involvement of AIF in STSinduced U1810 cell death in a cell-free system. Crude or AIF immunodepleted cytosolic extracts from STStreated U1810 cells ( Figure 5a ) were comparatively analysed for their ability to induce apoptosis in isolated (Figure 5b and c). The peripheral chromatin condensation observed in nuclei treated with crude cytosolic extracts was clearly reduced in nuclei treated with AIF-depleted cytosolic extracts, suggesting that AIF plays a key role in the induction of apoptosis by STS in U1810 cells. We were unsuccessful at using AIF as an siRNA target to determine whether inhibition of AIF would lead to STS resistance. Therefore, to further substantiate the role of AIF in intact cells, U1810 cells were microinjected with a neutralizing anti-AIF Ab before STS treatment ( Figure 6 ). As expected, this Ab prevented AIF translocation to the nucleus and concomitantly prevented the STS-induced chromatin condensation (Figure 6b ). In addition, anti-AIF-micro- injected cells were protected against STS toxicity for at least 12 h (Figure 6a ). In contrast, no protection was observed after microinjection of anti-CD86, an isotype-matched Ab used as a control. This experiment suggests that AIF is necessary for STS-mediated killing of U1810 cells.
U1810 cell death induction by transfection-enforced AIF expression
To further investigate the contribution of AIF to STSmediated apoptosis, AIF cDNA constructs fused in the C-terminus to GFP were expressed in U1810 cells. As shown in Figure 7 , overexpression of an AIF-GFP chimera targeted to the mitochondrial intermembrane space (Loeffler et al., 2001 ) (full-length AIF-GFP) was no more toxic than GFP alone. However, treatment of full AIF-GFP-transfected U1810 cells with STS for 4 h significantly enhanced STS cytotoxicity (Figure 7 , left part). The pan-caspase inhibitor z-VAD.fmk failed to prevent death of AIF-GFP-transfected U1810 cells treated with STS, indicating that death occurs in a caspase-independent fashion. When U1810 cells were transfected with a truncated AIF construct lacking the MLS (Delta1-100AIF-GFP) the resulting protein accumulated in the cytosol (data not shown; Loeffler et al., 2001) and cells progressively underwent apoptosis in a time-dependent manner ( Figure 7, right part) . Control experiments showed that U1810 cells transfected with GFP alone did not undergo apoptosis to the same extent ( Figure 7, right part) . These results together with (1) the results from microinjection of AIF neutralizing antibodies, (2) experiments on cell-free system using AIF immunodepleted extract, (3) the inability of caspase inhibition by z-VAD.fmk to reduce STS-induced nuclear events and cell death, (4) the results from the microinjection of active caspases-3 and Cyt c unravel the contribution of AIF to U1810 cell apoptosis.
Discussion
NSCLCs are frequently resistant to drug-and radiotherapy and complete clinical response to these treatments is very rear. Cellular mechanisms responsible for the resistance of NSCLC cells to treatment are numerous including inhibition of the apoptosis pathways (Volm and Rittgen, 2000) . Earlier, we have shown that U1810 cells were resistant to DNA damage-induced apoptosis but sensitive to the broad protein kinase inhibitor STS . This compound induced not only the Cyt c release and the activation of executioner caspases but also the release of the prototypic caspase-independent mitochondrial proapoptotic factor, AIF . In many cells, STSinduced activation of the Cyt c-caspase-dependent pathway does not require AIF release for the execution step of cell death (Joza et al., 2001) . However, in sublines of the mouse leukemia line L1210, STS induced apoptosis through caspase-dependent and -independent pathways; the STS triggered cell death can develop in spite of deficient caspase activation (Belmokhtar et al., 2001) . Pharmacological experiments with the broadspectrum inhibitor of caspases, z-VAD.fmk, revealed that caspases are responsible for the oligonucleosomal fragmentation and for the cleavage of the nuclear protein PARP in STS-treated U1810 cells. Inhibition of caspases, however, failed to prevent the STS-induced PS exposure to the outer leaflet of the plasma membrane and the increase of plasma membrane permeability. Similar results were obtained in activated T cells exposed to STS (Deas et al., 1998) . It has also been shown that apoptosis-associated plasma membrane alterations can be independent of caspases, since transfection of cells with caspase-3-resistant PAK2 abolishes formation of apoptotic bodies but not PS exposure (Rudel and Bokoch, 1997) . Moreover, z-VAD.fmk, at concentrations that completely block caspase activity, only delayed but did not prevent U1810 cell death. These results are consistent with the data recently obtained using human breast cancer cells treated with STS (Xue et al., 2003) . The authors found that although caspase-3 is essential for efficient execution of STS-mediated apoptosis, in caspase-3-deficient cell lines the critical lethal lesions were independent of caspase-3 (Xue et al., 2003) . In a series of different models, caspase inhibition fails to prevent membrane blebbing, does not maintain the clonogenic potential of cells and ultimately fails to rescue cells from lysis (Xiang et al., 1996; Hirsch et al., 1997; McCarthy et al., 1997) . Thus, although the induction of caspase activity plays a role in the execution of STS-induced apoptosis, U1810 cells can undergo cell death without caspase involvement.
The release of AIF from mitochondria could either precede or occur downstream of the release of Cyt c and subsequent caspase activation (Arnoult et al., 2002; Cande et al., 2002; Xue et al., 2003; Penninger and Kroemer, 2003 ). In our model, the translocation of AIF and Cyt c occurred simultaneously after STS treatment, in a caspase-independent fashion (Figure 2) . Confocal immunofluorescence microscopy studies revealed the appearance of AIF only in condensed nuclei (Figure 1b) , in support of an important role of AIF in chromatin condensation (Susin et al., 1999) . Since large-scale DNA fragmentation was observed at 4 h after STS treatment, we cannot rule out the possibility that low amounts of AIF (below detection level) were already in the nuclei at this time, although AIF was detectable in the nucleus until 8 h. As an alternative explanation, other caspaseindependent proapoptotic factor(s), different from AIF, might participate in caspase-independent DNA degradation. In fact, in some models of apoptosis, endonuclease G (EndoG) is released from mitochondria and translocates to the nucleus. EndoG can digest nuclear DNA to large-scale DNA fragments (Van Loo et al., 2001) . Interestingly, in Caenorhabditis elegans, the worm homolog of mammalian EndoG, CSP-6, and the homolog of AIF, WAH-1, cooperate to degrade DNA . Recently, an AIF homologous flavoprotein, AMID, has been described as a mitochondrial caspase-independent proapoptotic factor (Wu Irrespective of these considerations, our data indicate an important role of AIF in U1810 cell apoptosis, because (i) inhibition of AIF by microinjection of an anti-AIF Ab or depletion of AIF from cytosolic extracts prevented STS-induced chromatin condensation (Figures 5 and 6 ) and (ii) overexpression of AIF could facilitate U1810 cell apoptosis (Figure 7) .
Accumulating data suggest that defects in apoptosis signaling are a prerequisite for cancer development and/ or treatment (for review, see Mathiasen and Jaattela, 2002; Zhivotovsky and Orrenius, 2003) . We previously demonstrated that numerous NSCLC cell lines, including the U1810 cells, had a low degree of spontaneous apoptosis compared to SCLC cells (Sirzen et al., 1998) . These NSCLC cell lines were also resistant to treatment with g-radiation and chemotherapeutic agents, such as VP16 (Joseph et al., 2001) . In numerous cancer cells, caspases are simply not activated at all or are inhibited. For example, defects in the death receptor activated caspase-8-mediated pathway are frequent in human tumors (for review, see Mullauer et al., 2001) . Expression profiling of proapoptotic proteins in NSCLC cells suggests that the resistance of cells to undergo conventional treatment-induced apoptosis cannot be explained by the absence of executioner caspases (Joseph et al., 1999) . Moreover, alterations in the expression of the antiapoptotic proteins IAPs (Ekedahl et al., 2002) and HSP7O/72 (Ekedahl et al., 2003) were insufficient to explain the apoptosis resistance/sensitivity of these cells. It seems that the presence of active executioner caspases is not sufficient to promote nuclear apoptotic changes in U1810 cells without unknown yet additional factors. Consistent with these findings, microinjection of neither Cyt c nor active caspase-3 in the cytosol of U1810 cells led to mitochondrial release of AIF (Figures 3 and 4 ) and failed to promote high level of apoptosis-related nuclear changes, although 3T3 fibroblasts injected with the same amount of Cyt c or activated caspase readily entered into apoptosis. We also measured the cleavage of PARP using a specific Ab and found this cleavage in less than 15% of caspase-3-microinjected U1810 cells suggesting the existence of potent inhibitors of caspase-3 in NSCLC cells (data not shown). A deficiency in the relocalization of active caspase 3 into the nucleus of NSCLC cells was reported (Joseph et al., 2001) , but its contribution to resistance to apoptosis induction has not been yet demonstrated. In U1810 cells, active caspase-3 is translocated to the nucleus upon STS treatment (data not shown) and contributes to the apoptotic phenotype. Whether in these cells AIF can contribute to restore the efficiency of the caspase-dependent pathway still remains an open question. Consistent with this hypothesis, it has been demonstrated that enhanced expression of AIF stimulates caspase activation because AIF neutralizes HSP70 and hinders it from inhibiting caspase activation Schmitt et al., 2003) . Overall, the data reported here suggest that the activation of the mitochondrial Cyt c-caspase-dependent death pathway alone is not sufficient to promote U1810 cell death and that an AIF-dependent pathway is required to promote cell killing. These results support the paradigm that AIF (likely in association with other caspaseindependent factors) is important for the execution of apoptosis when the activation or action of caspases is precluded. Such an AIF-mediated caspase-independent pathways might provide new options for tumor cell killing in the context of chemotherapy resistance.
Materials and methods
Cell culture and modulation of apoptosis
The previously characterized NSCLC cell line U1810 (Bergh et al., 1985) was grown in RPMI 1640 Glutamax I medium (Invitrogen, Carlsbad, CA, USA) supplemented with 10% heat-inactivated fetal bovine serum and 1% penicillin-streptomycin at 371C, 5% CO 2 . The fibroblast cell line NIH/3T3 (3T3) cells were maintained in DMEM medium supplemented with 10% heat-inactivated fetal bovine serum and 1% penicillin-streptomycin (Invitrogen). At 24 h after setting in culture dishes with fresh medium, cells were treated with 1 mM STS (Sigma, St Louis, MO, USA). STS was dissolved in dimethyl sulfoxide at an initial stock concentration of 1 mM and stored at À201C in the dark. Subsequent dilutions were performed in PBS or in culture medium. Cells were incubated with STS alone or in combination with the broad-spectrum caspase inhibitor N-benzyloxycarbonyl-Val-Ala-Asp-fluoromethyl-ketone at the final concentration of 50 mM (z-VAD.fmk; Bachem, Basel, Switzerland). z-VAD.fmk was added 1 h before STS treatment. The cells density was kept at levels allowing exponential growth.
Immunofluorescence and annexin-V staining
Cells were fixed with 4% paraformaldehyde and 0.19% picric acid in PBS for 60 min, and washed in PBS for 10 min. The cells were further permeabilized with 0.1% SDS in PBS þ 1% FCS for 5 min before incubation with the 6H2-B4 mouse IgG1 anti-Cyt c antibody (Ab) (1 : 250; Pharmingen) for 1 h, or with the monoclonal mouse IgG2B anti-AIF Ab (mAb) (1 : 250; Santa Cruz, sc-13116). After three washes in PBS þ 1% FCS, cells were incubated in 1 : 500 FITC-conjugated anti-mouse (Fab 0 2) Abs (Sigma) for 30 min. The cells were washed three times in PBS þ 1% FCS followed by mounting in 80% glycerol in PBS. All samples were viewed and photographed using fluorescence microscope (DMLR, Leica).
For determination of the external exposition of phosphatidylserine (PS) residues, adherent U1810 cells were directly stained on Petri dishes with annexin-V-FITC (1/100 dilution; from the annexin-V-FITC kit, Immunotech, Beckman-Coulter) and propidium iodide (PI, 12.5 mg/ml; Immunotech, Beckman-Coulter) for 10 min on ice in the dark in binding buffer containing 10 mM Hepes-NaOH, pH 7.4, 140 mM NaCl, 2.5 mM CaCl 2 and analysed under fluorescence microscope within 1 h.
For confocal microscopy, cells were grown on coverslips and then stained with AIF antibodies as described above. Immediately before examination, cells were counterstained with PI (0.2 mg/ml). Cells were examined with a Leica TCS NT confocal microscope (Leica Microsystems, Rueil Malmaison, France) equipped with a 15 mW argon-krypton laser configured with an inverted Leica DM IRBE. Each image consisted of the middle section of eight optical sections performed at intervals of 6 mm in the z-axis. xy fields of 1024 Â 1024 pixels were scanned using an oil Pl Apo Â 63 objective. Chats were quantified and images were processed using the Leica TCS NT Software (PowerScan module).
Subcellular fractionation
Cells were harvested in extraction buffer containing 20 mM Hepes, 10 mM KCl, 1.5 mM MgCl 2 , 1mM EDTA, 1 mM EGTA, 1 mM DTT, 1 mM PMSF, 10 mg/ml leupeptine, 10 mg/ ml aprotinin and 10 mg/ml pepstatin and incubated for 1 h on ice. Then cells were homogenized for 40 strokes with a dounce homogenizer and centrifuged at 2500 g for 10 min at 41C to eliminate debris and unbroken cells. Supernatants were centrifuged at 15 000 g for 30 min at 41C and the resulting supernatants, also called the cytosolic fractions or cytosols, were aliquoted and kept at À801C.
Immunoblotting
In all, 50 mg of protein from each sample of the cytosolic fraction was loaded on a 12% polyacrylamide gel. After electrophoresis, the gels were blotted onto a nitrocellulose membrane (Amersham Life Sc.), which was then probed with a mouse Ab 7H8.2C12 (1/1000; Pharmingen) specifically recognizing the denatured form of Cyt c or a mouse Ab raised against AIF (1 : 1000, sc-13116; Santa Cruz Biotechnology Inc.). Immunoblot with anti-G3PDH (glyceraldehyde-3-phosphate dehydrogenase) rabbit polyclonal IgG Ab (1 : 1000; Trevigen, Gaithersburg, MD, USA) was used for standardization of protein loading. Primary antibodies binding was detected with horseradish peroxidase-conjugated goat antimouse or goat anti-rabbit IgGs (Bio-Rad) (both at dilution 1/ 1000) and visualized by enhanced chemiluminescence (ECL Plus) following the manufacturer's instructions (Amersham).
Analysis of nuclear fragmentation
DNA fragmentation (1 Â 10 6 cells/lane) was determined by horizontal agarose gel electrophoresis following published methods (Kawabe and Ochi, 1991) . Formation of highmolecular-weight DNA fragments was determined by using FIGE, as previously described (Zhivotovsky et al., 1994) . Briefly, following treatment, 1 Â 10 6 cells were resuspended in a solution containing 0.15 M NaCl, 2 mM KH 2 PO 4 , pH 6.8, 1 mM EGTA and 5 mM MgCl 2 . An equal volume of liquefied 1% low melting point agarose solution in the same buffer was added to this suspension, while gently mixing. The mixture was then liquefied into gel plug casting forms. The resulting agarose blocks were transferred into a solution containing 10 mM NaCl, 10 mM Tris-HCl, pH 9.5, 25 mM EDTA, 1% lauroylsarcosine and 200 mg/ml proteinase K, and incubated for 24 h at 501C with continuous agitation. The plugs were rinsed three times for periods of 2 h at 41C in 10 mM Tris-HCl, pH 8.0, and 1 mM EDTA (TE buffer). Subsequently, the plugs were stored until use at 41C in 50 mM EDTA, pH 8.0. Plugs were introduced into the 1% agarose gel and FIGE was carried out using a horizontal gel chamber, a power supply and a Switchback pulse controller purchased from Hoefer Scientific Instruments (USA). Electrophoresis was run at 170 V in 0.5 Â TBE (45 mM Tris, 1.25 mM EDTA, 45 mM boric acid, pH 8.0), at 121C, with the ramping rate changing from 0.8 to 30 s over a 24 h period, applying a forward to reverse ratio of 3 : 1. DNA size calibration was performed using two sets of pulse markers, chromosomes from Saccharomyces cerevisiae (225-2200 kbp) and a mixture of lDNA HindIII fragments, lDNA and lDNA concatemers (0.1-200 kbp) purchased from Sigma. DNA was stained with ethidium bromide, visualized using a 305 nm UV light source and photographed using a Polaroid 665 positive/negative film.
Clonogenic cell survival
U1810 cells were seeded into 25-cm 2 flasks and allowed to grow until subconfluency. The cells were treated for 18 h with z-VAD.fmk (50 mM), STS (1 mM) alone or in combination with z-VAD.fmk. At the end of the incubation time, cells were collected from the monolayer with trypsin and washed in RPMI medium. The cells (2000/ml) were plated in drug-free medium in triplicate into six-well dishes. After incubation for 10 days, the cells were stained with 0.2% crystal violet in 900 ml methanol to allow macroscopic estimation. The surviving fractions following given treatments were calculated as a percentage of viable cells in untreated cultures.
Microinjection and dead cells quantification
Before experiment, cells were plated on Petri dishes (20 cm 2 ). The next day when they reached subconfluency, the medium was changed and cells were microinjected with Cyt c (20 mM; Merck), active caspase-3 (500 ng/ml; Alexis Biochemical), mouse IgG2b mAb raised against AIF (5 mg/ml) or an isotype-matching anti-CD86 mAb (5 mg/ml; Pharmingen) used as a control. To mark injected cells (usually 50-100 per experiment), 50 mg/ml dextran conjugated with Alexa Fluor 488 (Molecular Probes) was added to the injection mixtures. Microinjection at 150 hPa (2 s) was performed using a DMIL inverted microscope (Leica) fitted with an Eppendorf pressure injector model 5242 and micromanipulator E (Leitz). Microinjection needles (femtotips, type I) were from Eppendorf.
At the indicated time, the AIF localization was revealed by immunofluorescence and nuclei were visualized by staining with Hoechst 33342. Injected cells were scored as either apoptotic due to their round shape and condensed nuclei, or alive due to their spindle shape and normal nuclear morphology.
Cell-free system of apoptosis and immunodepletion of AIF Cytosols from U1810 cells stimulated for 12 h with 1 mM STS were prepared as described above. Immunodepletion of AIF from cytosolic fraction was performed using an anti-AIF Ab (mouse IgG mAb, sc-13116; Santa Cruz) and protein A/G coupled to agarose beads (100-200 mg of Ab per ml beads for 3 h at RT followed by three washes in Hepes-KOH, pH 6.75; Amersham Pharmacia Biotech). A 50 ml portion of packed beads was incubated with the cytosols of STS-treated U1810 (300-500 mg protein) in a 1 ml volume for 18 h at 41C, followed by removal of beads (2000 g for 10 min at 41C). The supernatants were then tested for the efficiency of immunodepletion by Western blot technique using the same anti-AIF Ab. Nuclei from U1810 cells were purified on a sucrose gradient, as previously explained (Wodd JCB 1990) and were diluted in HNB buffer (10 mM Pipes, 10 mM KCl, 10 mM MgCl 2 , 1 mM DTT, 10 mM cytochalasin B, 1 mM PMSF, pH 7.4). Nuclei were added to the untreated or AIF immunodepleted cytosol at the final concentration of 1 Â 10 3 /ml, incubated for 90 min at 371C, stained with 10 mg/ml Hoechst 33342 and examined by fluorescence microscopy at 365 nm. The day before transfection, 20 Â 10 3 were seeded per well of chamber slides. The plasmid DNA-lipofectamine 2000 complex was prepared according to the manufacturer's instructions. At the end of the 3-h incubation period with lipofectamine 2000-DNA complex, U1810 cells were washed and re-fed with a regular complete medium. After 24 h, cells were stimulated with STS. At indicated times, nuclei were stained with Hoechst 33342 and the frequency of apoptotic cells was determined by counting under the microscope.
Transient transfection protocol
Abbreviations AIF, apoptosis inducing factor; Dc m , inner mitochondrial transmembrane potential; MPT, mitochondrial permeability transition; G3PDH, glyceraldehyde-3-phosphate dehydrogenase; NSCLC, non-small-cell lung carcinoma; SCLC, small cell lung carcinoma; STS, staurosporine; PI, propidium iodide; PARP, poly(ADP-ribose) polymerase.
